6-Chloro-1-phenyl-1,2,3,4-tetrahydro-isoquinolin-7-ol

ID: ALA65397

Chembl Id: CHEMBL65397

PubChem CID: 14198590

Max Phase: Preclinical

Molecular Formula: C15H14ClNO

Molecular Weight: 259.74

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Oc1cc2c(cc1Cl)CCN[C@H]2c1ccccc1

Standard InChI:  InChI=1S/C15H14ClNO/c16-13-8-11-6-7-17-15(12(11)9-14(13)18)10-4-2-1-3-5-10/h1-5,8-9,15,17-18H,6-7H2/t15-/m0/s1

Standard InChI Key:  VXQGSKLYCJFAKI-HNNXBMFYSA-N

Associated Targets(Human)

DRD1 Tclin Dopamine D1 receptor (9720 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD2 Tclin Dopamine D2 receptor (23596 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Drd1 Dopamine D1 receptor (1900 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Drd2 Dopamine D2 receptor (7893 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Drd1 Dopamine receptors; D1 & D2 (258 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 259.74Molecular Weight (Monoisotopic): 259.0764AlogP: 3.28#Rotatable Bonds: 1
Polar Surface Area: 32.26Molecular Species: NEUTRALHBA: 2HBD: 2
#RO5 Violations: HBA (Lipinski): 2HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 7.55CX Basic pKa: 8.44CX LogP: 3.12CX LogD: 2.96
Aromatic Rings: 2Heavy Atoms: 18QED Weighted: 0.82Np Likeness Score: 0.43

References

1. Charifson PS, Wyrick SD, Hoffman AJ, Simmons RM, Bowen JP, McDougald DL, Mailman RB..  (1988)  Synthesis and pharmacological characterization of 1-phenyl-, 4-phenyl-, and 1-benzyl-1,2,3,4-tetrahydroisoquinolines as dopamine receptor ligands.,  31  (10): [PMID:3050089] [10.1021/jm00118a012]
2. Charifson PS, Bowen JP, Wyrick SD, Hoffman AJ, Cory M, McPhail AT, Mailman RB..  (1989)  Conformational analysis and molecular modeling of 1-phenyl-, 4-phenyl-, and 1-benzyl-1,2,3,4-tetrahydroisoquinolines as D1 dopamine receptor ligands.,  32  (9): [PMID:2527994] [10.1021/jm00129a006]

Source